Craniofacial Postherpetic Neuralgia
Conditions
Interventions
Electrical stimulation group:gasserian ganglion stimulation
Sponsors
Xuanwu Hospital Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Aged 18-75 years, both sexes eligible; (2) Clinically diagnosed with craniofacial postherpetic neuralgia (PHN); (3) Disease duration >=3 months, Numerical Rating Scale (NRS) score >=6; (4) Inadequate pain relief from prior therapies (pharmacotherapy, nerve blocks, radiofrequency ablation); (5) Stable analgesic regimen (if applicable) maintained for >=4 weeks; (6) Signed informed consent from participants or legal guardians.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Alcoholism or drug dependence; 3. DRGS-related contraindications include but are not limited to severe coagulation dysfunction, heart, liver and kidney insufficiency, bedsores in the area to be operated, local infection, etc.; 4. History of malignant tumors; 5. Combined with mental illness such as somatization disorder; 6. Unwilling to undergo treatment or follow-up evaluation; 7. Participated in other clinical trials within 3 months prior to enrollment in this clinical trial; 8. There are other situations that the investigator considers unsuitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical Rating Scale,NRS; | — |
Secondary
| Measure | Time frame |
|---|---|
| (Barrow Neurologic Institute,BNI);Hamilton Depression Scale, HAMD;Hamilton Anxiety Scale, HAMA;Pittsburgh sleep quality index,PSQI; | — |
Countries
China
Contacts
Public ContactZhu Hongwei
Xuanwu Hospital Capital Medical University
Outcome results
None listed